Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ernő Duda"'
Visible Light-Generated Antiviral Effect on Plasmonic Ag-TiO2-Based Reactive Nanocomposite Thin Film
Autor:
Zsolt Boldogkői, Zsolt Csabai, Dóra Tombácz, László Janovák, Lilla Balassa, Ágota Deák, Péter S. Tóth, Csaba Janáky, Ernő Duda, Imre Dékány
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
The recent coronavirus pandemic pointed out the vulnerability of humanity to new emerging infectious diseases. Experts warn that future pandemics may emerge more frequently with greater devastating effects on population health and the world economy.
Externí odkaz:
https://doaj.org/article/583958be8ca24a02a3619c89fb0416b1
Publikováno v:
Antibodies, Vol 4, Iss 2, Pp 123-140 (2015)
Anti-tumor necrosis factor (TNF) monoclonal antibodies and TNF receptor ectodomain fusion protein are in clinical use to neutralize circulating TNF and ameliorate symptoms of many autoimmune diseases and pathological conditions with chronic inflammat
Externí odkaz:
https://doaj.org/article/521b9902f5a8467988cf686bb4d47597
Autor:
Ernő Duda
Publikováno v:
Magyar Tudomány.
Autor:
Ernő, Duda
Publikováno v:
Magyar Nőorvosok Lapja; Feb2023, Vol. 86 Issue 1, p3-7, 5p
Publikováno v:
Orvosi hetilap. 161(21)
The first Hungarian COVID-19 case was reported on March 4, 2020 by Hungarian officials. Healthcare workers (HCWs) are at the highest risk of contracting the novel coronavirus (SARS-CoV-2), with 12% of total coronavirus cases confirmed among them rece
Publikováno v:
Antibodies, Vol 4, Iss 2, Pp 123-140 (2015)
Antibodies
Volume 4
Issue 2
Pages 123-140
Antibodies
Volume 4
Issue 2
Pages 123-140
Anti-tumor necrosis factor (TNF) monoclonal antibodies and TNF receptor ectodomain fusion protein are in clinical use to neutralize circulating TNF and ameliorate symptoms of many autoimmune diseases and pathological conditions with chronic inflammat
Publikováno v:
Hungarian Medical Journal / Orvosi Hetilap; 2020, Vol. 161 Issue 21, p854-860, 7p
Autor:
Aniko Keller-Pinter, Ernő Duda, Erzsébet Kusz, Tamás Letoha, Csaba Ékes, Gerda Szakonyi, László Szilák, Csongor Kolozsi
Publikováno v:
European Journal of Pharmaceutical Sciences. 49:550-555
The long awaited breakthrough of gene therapy significantly depends on the in vivo efficiency of targeted intracellular delivery. Hidden details of cellular uptake present a great hurdle for non-viral gene delivery with liposomes. Growing scientific
Autor:
Alois Sonnleitner, Ibolya Horváth, Zsolt Balogi, Kata Juhasz, László Vígh, Ernő Duda, Roland Thuenauer, Andrea Spachinger
Publikováno v:
Current Pharmaceutical Design
Scopus-Elsevier
Scopus-Elsevier
Tumor specific cell surface localization and release of the stress inducible heat shock protein 70 (Hsp70) stimulate the immune system against cancer cells. A key immune stimulatory function of tumor-derived Hsp70 has been exemplified with the murine